Extracellular signal-regulated kinases (Erks), members of the MAPK superfamily, play an important role in cell proliferation and differentiation. In this study we employed a dominant negative approach to determine the role of Erks in the regulation of human osteoblastic (HOB) cell function. HOB cells were transduced with a pseudotyped retrovirus encoding either a mutated Erk1 protein with a dominant negative action against both Erk1 and Erk2 (Erk1DN cells) or the LacZ protein (LacZ cells) as a control. Both basal and growth factor-stimulated MAPK activity and cell proliferation were inhibited in Erk1DN cells. Expression of Erk1DN protein suppressed both osteoblast differentiation and matrix mineralization by decreasing alkaline phosphatase activity and the deposition of bone matrix proteins. Cell adhesion to collagen, osteopontin, and vitronectin was decreased in Erk1DN cells as compared with LacZ cells. Cell spreading and migration on these matrices were also inhibited. In Erk1DN cells, expression of αβ 1 , α v β 3 , and α v β 5 integrins on the surface was decreased. Metabolic labeling indicated that the synthesis of these integrins was inhibited in Erk1DN cells. These data suggest that Erks are not only essential for the growth and differentiation of osteoblasts but also are important for osteoblast adhesion, spreading, migration, and integrin expression.
Introduction
For bone formation to occur, osteoblast precursor cells must migrate from bone marrow compartment to bone surface where they differentiate and deposit bone matrix. Several growth factors including FGF-2, TGF-β, and BMP-2 not only are potent chemotactic agents for osteoblasts but also have profound effects on their growth and differentiation (1) (2) (3) (4) (5) . In addition to growth factors, the interaction between integrins and the extracellular matrix proteins also governs cell migration, adhesion, proliferation, and differentiation (6) (7) (8) (9) (10) . Human osteoblastic (HOB) cells express a repertoire of integrins, which interact with bone matrix proteins such as osteopontin, bone sialoprotein, vitronectin, type I collagen, and fibronectin (11) (12) (13) (14) (15) . These interactions have been shown to regulate osteoblast growth and differentiation (16) (17) (18) (19) (20) (21) (22) (23) .
Numerous signal transduction pathways are induced by integrin-matrix interactions in a variety of cell systems (6) (7) (8) (9) (10) . The Ras/MAPK signal transduction pathway is one of the bestcharacterized pathways. Adhesion of cells to collagen, fibronectin, or vitronectin has been shown to induce MAPK activity in many cell systems (24, 25) . Growth factors have also been and BamH1 sites of SFG retroviral vector as described previously (38, 39) . For generation of retroviral particles pseudotyped with vesicular stomatitis virus G glycoprotein (VSV-G), SFGErk1 K71R viral vector was transfected using LipofectAmine into the 293GPG packaging cell line, which expresses the MuLV gag-pol, and also expresses the VSV-G protein under tetracycline regulation (38, 39) . The conditioned medium was harvested daily after the withdrawal of tetracycline, and the media harvested from day 3 to day 7 containing the highest titer of viral particles (≥ 5 x 10 6 cfu/ml) were combined and used for transduction. Before transduction, the medium was filtered through a 0.45 µ membrane and polybrene (hexadimethrine bromide, 8 µg/ml) was added to the virus medium. As a negative control, a virus carrying the SFG-LacZ cDNA was generated in the same fashion. This pseudotyped retrovirus has been shown to have no effect on osteoblast differentiation (40) .
Transduction of human osteoblastic cells with pseudotyped retroviruses
The day before transduction, HOB cells were seeded in 150 mm culture dishes (1x10 6 /dish). The next day, 25 ml of conditioned medium containing Erk1DN or LacZ virus was added to each dish, and the incubation continued for another 24 h. At the end of the incubation period, the virus medium was removed, and cells were grown to confluence in α-MEM with 10% HIFBS.
Immunostaining of the transduced cells for Erk proteins
HOB cells were seeded onto cover slips and allowed to recover overnight. Cells were then transduced with either LacZ or Erk1DN virus for 24 h followed by further incubation in the growth medium for additional 48 h. Cells were washed twice with phosphate-buffered saline (PBS) and fixed in 4% paraformaldehyde in PBS for 15 min. After washing twice with PBS, cells were treated with ammonium chloride to quench any remaining paraformaldehyde. Cells were again washed with PBS and then permealized with 0.1% Triton X-100 in PBS (PT), followed by incubation with anti-pan Erk antibody (1:400) in PT containing 1% bovine serum albumin (BSA) (PTB) for 1 h at room temperature. After washing 3 times with PT, cells were incubated with Cy3-conjugated goat anti-mouse antibody (1:200) in PTB for 1 h. Finally, after extensive washing with PT, the cover slips were mounted on slides, and fluorescence was observed using an epifluorescence microscope.
MAPK activity assay
Confluent cells in 100 mm culture dishes were incubated in α-MEM containing 0.2 % HIFBS for 24 h followed by treatment with designated growth factor for 10 min at 37 o C. After two PBS washes, the cell layers were extracted with 0.5 ml of MAPK assay buffer consisting of 50 mM Tris HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 5 mM NaF, phosphatase inhibitor cocktail II (0.4 ml/10 ml), and protease inhibitor cocktail (0.4 ml/10 ml). Extracts were homogenized by passing through 26 G needles 10 times. After micro-centrifugation, the supernatant was transferred to a new tube. MAPK activity in the cell extract (20 µg protein) was measured by using the MAPK assay kit with PHAS-1 protein as the substrate and [γ-32 P]ATP according to the protocol supplied by the manufacturer (Stratagene).
Western blot analysis
Cell extracts (40 µg protein), isolated as described above, were subjected to SDS-PAGE and transblotted to Immobilon-P membranes. The membranes were dried completely and then incubated with the appropriate primary antibody (1:1000) in PBS containing 1% casein and 0.04% Tween 20 (PCT) for 1 h at room temperature. After three PBS washes, the membranes were incubated with a horseradish peroxidase-conjugated secondary antibody (1:2000 in PCT) for 30 min followed by another four PBS washes. Protein bands were visualized by chemiluminescence using an ECL kit.
Nuclear extract preparation and electrophoresis mobility shift assay (EMSA)
Nuclear extracts were prepared as previously described (31) . Briefly, HOB cells were lysed in ice-cold buffer containing 10 mM Hepes-KOH, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and 0.6% NP-40.
After centrifugation, nuclear pellets were extracted with a high salt buffer (20 mM Hepes-KOH, pH 7.9, 1.2 mM MgCl 2 , 420 mM NaCl, 25% glycerol, 0.5 mM DTT, 0.5 mM PMSF, 10 µg/ml each of leupeptin and pepstatin, and 25 µg/ml aprotinin) for 1 h. For EMSA, radioactive 
Cell proliferation assay
Viral-transduced HOB cells were seeded in a 24 well plate (20,000 cells/well) and allowed to recover overnight in α-MEM with 10% HIFBS. The medium was removed, and cells were incubated in 0.2% HIFBS medium for another 24 h. [ 3 H]Thymidine (2 µCi/well) in α-MEM containing 0.2 % HIFBS was added with the appropriate growth factor and the incubation continued for another 24 h. [ 3 H]Thymidine incorporated into DNA was measured after trichloroacetic acid precipitation, ethanol washing, and alkali extraction as described previously (34) .
Alkaline phosphatase activity assay
Confluent viral-transduced cells in 24 well plates were washed three times with TBS (Tris buffered saline, 20 mM Tris HCl, pH 7.4, and 0.9% NaCl), scraped into 0.5 ml of 50 mM Tris HCl, pH 7.4, and sonicated in a Fisher Dismembranetor (30-40% of maximum strength).
Alkaline phosphatase activity in the sonicate was measured as described previously (34) .
Matrix mineralization assay
Mineralized matrix was detected by alizarin red-S staining for deposited calcium.
Osteoblasts in 6 well culture plates were incubated for 28 days in mineralization medium consisted of α-MEM, 10% HIFBS, ascorbic acid (50 µg/ml) and β-glycerophosphate (10 mM).
At the end of incubation, cells were washed 3 times with PBS and fixed in ice-cold 70 % ethanol for 1 h. After washing with water 3 times, the cells were incubated with 0.4% alizarin red-S in water for 10 min at room temperature followed by 5 washes with water and final incubation in PBS for 15 min.
Cell adhesion and spreading assays
Adhesion to type I collagen, osteopontin, or vitronectin was performed as previously described (33) . Briefly, single cell suspensions were obtained after collagenase and trypsin/EDTA digestion. After rinsing with serum-free α-MEM supplemented with 0.1% BSA, cells were seeded to wells pre-coated with either BSA or a matrix protein (4 x 10 4 cells/cm 2 ).
After 1 h incubation for adhesion measurement or 2 h for spreading assay at 37 o C, the wells were washed with PBS to remove the non-adherent cells. Adherent cells were fixed and stained with 0.5% toluidine blue in 4% paraformaldehyde. To obtain the adherent cell number, stained cells were extracted with 1% SDS, and the absorbance at 630 nm was measured. For analysis of cell spreading, cell morphology was recorded by photography using phase contrast microscope.
For adhesion-induced MAPK assays, cells were adhered to matrices for 20 min and lysed in MAPK assay buffer as described above.
Cell migration assay
The day before the assay, Costar transwell membranes were coated with collagen (100 ng), osteopontin (250 ng), or vitronectin (250 ng) for 3 h at room temperature. Single cell suspensions obtained as described above for the adhesion assay were delivered into the transwells (100,000 cells in 0.1 ml/transwell) suspended inside the bottom wells containing 0.6 ml of α-MEM with 0.1% BSA and 25 ng/ml FGF-2. After overnight migration in an incubator, cells on the membranes were fixed and stained using Leukostat kit. The non-migrated cells on top of the membranes were removed with cold PBS-soaked cotton swabs and the migrated cells on the bottom side of the membranes were counted under the microscope with the aid of a grid.
A total of 9 separate fields (3 x 10 -4 cm 2 /field) were counted for each sample and the average 
Protein measurement and quantification of band intensity on X-ray films
Protein concentration was measured by using the BioRad protein DC assay kit. To quantify the band intensity, X-ray films were subjected to image analysis using ISS SepraScan 2001 (Integrated Separation Systems, Natick, MA).
Statistics
Statistical analyses were performed using Student's unpaired t-test. Each experiment was performed at least twice and the representative data were presented as mean ± SEM.
Results

Erk/MAPK activity is induced upon adhesion of human osteoblastic cells to bone matrix proteins
HOB cells have been shown to adhere to numerous bone matrix proteins, including type I collagen, osteopontin, vitronectin, fibronectin, and bone sialoprotein, in an integrin-dependent fashion (12, 15, 33) . It has been well established in various cell systems that Erk/MAPK activity is stimulated by cell adhesion to matrix (6, (8) (9) (10) . When HOB cells adhered to type I collagen, fibronectin, osteopontin, or vitronectin, both Erk-2 [major band at 42 kDa, the main Erk expressed in normal human osteoblasts (27) ] and Erk-1 (minor band at 44 kDa) activities were consistently enhanced (4.9-to 7.4-fold after normalization with the corresponding tubulin protein level) as determined by Western blot analysis using antibody against the active phosphorylated Erks (p-Erk) (Figure 1) . Likewise, the total MAPK enzymatic activity, determined by the incorporation of 32 P into PHAS-1 substrate, was stimulated 4-to 6-fold upon HOB cell adhesion to these matrix proteins (Figure 1) .
Generation of human osteoblastic cell lines expressing a dominant negative Erk1 protein
Since Erks mediate both growth factor-and integrin-induced signal transduction, it is likely that they play important role in the regulation of osteoblast function. We employed the dominant negative Erk1 K71R (Erk1DN) protein, which can inhibit both Erk1 and Erk2 Results of EMSA demonstrated that the expression of Erk1DN protein strongly inhibited AP-1 binding activity to its consensus oligonucleotide to 10% of LacZ control cell level ( Figure 4C ).
Moreover, the activity of RSK2, another downstream effector of Erk (44) was inhibited by 54% in Erk1DN cells as compared with the LacZ cells after normalization for protein loading, both under basal condition and after FGF-2 stimulation ( Figure 5 ). These combined data indicated that Erk1 K71R cDNA introduced into HOB cells by using pseudotyped retrovirus was expressed and was functional in both basal and growth factor-stimulated Erk1DN cells.
Expression of Erk1DN protein inhibited the proliferation and differentiation of human osteoblastic cells
After establishing the expression of functional Erk1DN protein, we examined the effect of this protein on HOB cell proliferation. As shown in Figure 6 , the basal DNA synthesis, as measured by [ The role of MAPK in cell proliferation and differentiation has been well documented in a variety of cell systems (26) . Our data demonstrate that Erk/MAPK mediates FGF-2-and TGF-β-stimulated proliferation in human osteoblastic cells. In addition, our observation that Erk/MAPK is activated by osteoblast adhesion to several bone matrix proteins, such as type I collagen, fibronectin, vitronectin, and osteopontin, is consistent with earlier reports using other cell systems (6, (8) (9) (10) . In osteoblast differentiation, alkaline phosphatase activity is increased early in the process, and it is this increase that commits the cells to differentiate into osteoblast lineage (49) . A shortage or complete deficiency in alkaline phosphatase activity delays or prevents matrix mineralization in osteoblasts (50) . In line with these reports, inhibition of Erk activity in osteoblasts decreases not only alkaline phosphatase activity but also matrix suggests that the Erk/MAPK pathway is critical for osteoblast integrin expression, which, in turn, dictates cell migration, adhesion, and spreading on matrices since integrins play important role in these processes. MAPK has previously been shown to be associated with the up-regulation of integrins (56, 57) . Our data provide direct evidence linking Erk/MAPK signaling to the expression of αβ 1 , α v β 3 , and α v β 5 integrins. Although the reduction of surface integrin levels in Erk1DN cells can be attributed in part to the decreased synthesis, the latter is only to a moderate degree (23-36% inhibition) as compared with the former (46-57% reduction).
Therefore, other mechanism(s) may also be regulated by Erk/MAPK to affect the integrin levels on cell surface. The extent of inhibition on cell adhesion and migration in Erk1DN cells (approximately 70% inhibition with the exception of migration on collagen) cannot be fully accounted for by the degree of reduction in surface integrin levels. These data suggest that Erk may affect the integrin activity. Additional studies will be required to confirm these speculations. Since cell migration is preceded by cell adhesion, the inhibition of cell migration in Erk1DN cells may simply be the consequence of decreased cell adhesion. In addition, cells need to spread directionally toward chemokine during migration, the decreased ability of Erk1DN cells to spread will hinder cell migration.
Several mechanisms may mediate the inhibition of osteoblast activity by Erk1DN protein.
Among these, the inhibition of AP-1 activity appears to be a critical factor (58) . It is important to note that the expression of type I collagen, osteocalcin, and osteopontin has been shown to be dependent on AP-1 (59) (60) (61) . Other transcription factors may also contribute to the Erk/MAPK effects, especially the aforementioned Cbfa1 since the activation of Cbfa1 is dependent on
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by guest on August 17, 2017 http://www.jbc.org/ Downloaded from Erk/MAPK (26, 44, 55) . Cbfa1 can regulate the expression of bone sialoprotein, type I collagen, osteocalcin, and osteopontin in osteoblasts (62) (63) (64) (65) . Therefore, the inhibition of Erk activity in Erk1DN cells will prevent the activation of Cbfa1 leading to the inhibition of bone matrix protein deposition.
Recently, the mutated gene for Coffin-Lowry Syndrome (CLS) has been identified as Rsk2, ribosomal S6 kinase 2 (66, 67) . This syndrome is characterized by a variety of clinical symptoms including mental retardation, delayed closure of fontanelles, digital dysmorphism, progressive skeletal deformations, osteopenia, and delayed bone age (68) (69) (70) (71) . Since Rsk2 is a substrate that is phosphorylated and activated by Erk (44) 
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